{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:45:25Z","timestamp":1792734325482,"version":"4.5.0"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Recent advances in therapy for non\u2013small cell lung carcinoma have shown that a personalized approach to treatment has the potential to significantly reduce lung cancer mortality. Concurrently, endoscopic ultrasound transbronchial needle aspiration has emerged as an accurate and sensitive tool for the diagnosis and staging of this disease. As knowledge of the molecular mechanisms that drive lung cancer progression increases, the amount of information that must be derived from a tumor specimen will also increase. Recent clinical studies have demonstrated that small specimens acquired by endoscopic ultrasound transbronchial needle aspiration are sufficient for molecular testing if specimen acquisition and processing are done with these needs in mind. Optimum use of this procedure requires a coordinated effort between the bronchoscopist and the cytopathologist to collect and triage specimens for diagnostic testing. When feasible, rapid onsite evaluation should be performed to assess the specimen for both diagnostic quality and quantity and to allocate the specimen for cell-block and possible immunohistochemistry and molecular studies. It is necessary for pulmonologists and bronchoscopists to understand the rationale for histologic and molecular testing of lung cancer diagnostic specimens and to ensure that specimens are acquired and processed in a fashion that provides information from small cytologic specimens that is sufficient to guide treatment in this era of targeted therapy.<\/jats:p>","DOI":"10.1164\/rccm.201107-1199ci","type":"journal-article","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T20:39:46Z","timestamp":1319747986000},"page":"606-611","source":"Crossref","is-referenced-by-count":60,"title":["Acquisition and Processing of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Specimens in the Era of Targeted Lung Cancer Chemotherapy"],"prefix":"10.1093","volume":"185","author":[{"given":"William","family":"Bulman","sequence":"first","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Saqi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Columbia University Medical Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Powell","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,3,15]]},"reference":[{"key":"2026032101152740900_bib1","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"2026032101152740900_bib2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1164\/rccm.201103-0370UP","article-title":"Update in lung cancer and oncological disorders 2010","volume":"184","author":"Halmos","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101152740900_bib3","first-page":"A5160","article-title":"Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis and staging of thoracic malignancy","volume":"181","author":"Bulman","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032101152740900_bib4","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1200\/JCO.2004.11.022","article-title":"Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer","volume":"22","author":"Johnson","year":"2004","journal-title":"J Clin Oncol"},{"key":"2026032101152740900_bib5","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer","volume":"355","author":"Sandler","year":"2006","journal-title":"N Engl J Med"},{"key":"2026032101152740900_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/JTO.0b013e3181f7c6d4","article-title":"Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer","volume":"6","author":"Scagliotti","year":"2011","journal-title":"J Thorac Oncol"},{"key":"2026032101152740900_bib7","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1200\/JCO.2010.28.8126","article-title":"The evolving role of histology in the management of advanced non-small-cell lung cancer","volume":"28","author":"Langer","year":"2010","journal-title":"J Clin Oncol"},{"key":"2026032101152740900_bib8","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1038\/onc.2009.199","article-title":"Predictive value of EGFR and her2 overexpression in advanced non-small-cell lung cancer","volume":"28","author":"Hirsch","year":"2009","journal-title":"Oncogene"},{"key":"2026032101152740900_bib9","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N Engl J Med"},{"key":"2026032101152740900_bib10","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"key":"2026032101152740900_bib11","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/1078-0432.1167.11.3","article-title":"The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers","volume":"11","author":"Tokumo","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2026032101152740900_bib12","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/onc.2009.197","article-title":"Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors","volume":"28","author":"John","year":"2009","journal-title":"Oncogene"},{"key":"2026032101152740900_bib13","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","article-title":"Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR","volume":"362","author":"Maemondo","year":"2010","journal-title":"N Engl J Med"},{"key":"2026032101152740900_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1470-2045(09)70364-X","article-title":"Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (wjtog3405): an open label, randomised phase 3 trial","volume":"11","author":"Mitsudomi","year":"2010","journal-title":"Lancet Oncol"},{"key":"2026032101152740900_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.18632\/oncotarget.186","article-title":"EGFR-mutated lung cancer: a paradigm of molecular oncology","volume":"1","author":"Zhang","year":"2010","journal-title":"Oncotarget"},{"key":"2026032101152740900_bib16","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1200\/JCO.2010.31.8923","article-title":"American Society of Clinical Oncology provisional clinical opinion: epidermal growth factor receptor (EGFR) mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy","volume":"29","author":"Keedy","year":"2011","journal-title":"J Clin Oncol"},{"key":"2026032101152740900_bib17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming eml4-alk fusion gene in non-small-cell lung cancer","volume":"448","author":"Soda","year":"2007","journal-title":"Nature"},{"key":"2026032101152740900_bib18","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","article-title":"Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer","volume":"363","author":"Kwak","year":"2010","journal-title":"N Engl J Med"},{"key":"2026032101152740900_bib19","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/JTO.0b013e3181e7616e","article-title":"Biomarkers are here to stay for clinical research and standard care","volume":"5","author":"Bunn","year":"2010","journal-title":"J Thorac Oncol"},{"key":"2026032101152740900_bib20","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1158\/1940-6207.CAPR-11-0232","article-title":"The battle to personalize lung cancer prevention through reverse migration","volume":"4","author":"Gold","year":"2011","journal-title":"Cancer Prev Res (Phila Pa)"},{"key":"2026032101152740900_bib21","doi-asserted-by":"crossref","first-page":"131S","DOI":"10.1378\/chest.07-1357","article-title":"Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)","volume":"132","author":"Rivera","year":"2007","journal-title":"Chest"},{"key":"2026032101152740900_bib22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/thx.2008.109868","article-title":"Test performance of endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer: systematic review and meta-analysis","volume":"64","author":"Adams","year":"2009","journal-title":"Thorax"},{"key":"2026032101152740900_bib23","doi-asserted-by":"crossref","first-page":"202S","DOI":"10.1378\/chest.07-1362","article-title":"Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)","volume":"132","author":"Detterbeck","year":"2007","journal-title":"Chest"},{"key":"2026032101152740900_bib24","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/JTO.0b013e3181753b5e","article-title":"Diagnosis of mediastinal adenopathy-real-time endobronchial ultrasound guided needle aspiration versus mediastinoscopy","volume":"3","author":"Ernst","year":"2008","journal-title":"J Thorac Oncol"},{"key":"2026032101152740900_bib25","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1001\/jama.2010.1705","article-title":"Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial","volume":"304","author":"Annema","year":"2010","journal-title":"JAMA"},{"key":"2026032101152740900_bib26","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.lungcan.2009.04.019","article-title":"Economic analysis of combined endoscopic and endobronchial ultrasound in the evaluation of patients with suspected non-small cell lung cancer","volume":"67","author":"Harewood","year":"2010","journal-title":"Lung Cancer"},{"key":"2026032101152740900_bib27","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jtcvs.2003.11.020","article-title":"Combined bronchoscopy, mediastinoscopy, and thoracotomy for lung cancer: Who benefits?","volume":"127","author":"Kim","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026032101152740900_bib28","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/MCP.0b013e32832b8a45","article-title":"Mediastinal staging procedures in lung cancer: EBUS, TBNA and mediastinoscopy","volume":"15","author":"Medford","year":"2009","journal-title":"Curr Opin Pulm Med"},{"key":"2026032101152740900_bib29","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.athoracsur.2010.06.052","article-title":"Mediastinoscopy in patients with lung cancer and negative endobronchial ultrasound guided needle aspiration","volume":"90","author":"Defranchi","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"2026032101152740900_bib30","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/cncy.20103","article-title":"Cytology of endobronchial ultrasound-guided transbronchial needle aspiration versus conventional transbronchial needle aspiration","volume":"118","author":"Stoll","year":"2010","journal-title":"Cancer Cytopathol"},{"key":"2026032101152740900_bib31","article-title":"Endobronchial ultrasound-guided transbronchial needle aspirate (EBUS-TBNA): a proposal for on-site adequacy criteria","author":"Nayak","journal-title":"Diagn Cytopathol"},{"key":"2026032101152740900_bib32","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1309\/BLLQF8KDHWW6MJNQ","article-title":"Endobronchial ultrasound-guided transbronchial fine-needle aspiration: the University of Minnesota experience, with emphasis on usefulness, adequacy assessment, and diagnostic difficulties","volume":"130","author":"Alsharif","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"2026032101152740900_bib33","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejcts.2008.09.022","article-title":"Endobronchial ultrasound-guided needle aspiration in the non-small cell lung cancer staging","volume":"35","author":"Szlubowski","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026032101152740900_bib34","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.athoracsur.2009.05.021","article-title":"Endobronchial ultrasound as a diagnostic tool in patients with mediastinal lymphadenopathy","volume":"88","author":"Gilbert","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"2026032101152740900_bib35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/LBR.0b013e3182273b41","article-title":"Comparison of 21-gauge and 22-gauge needles for endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes","volume":"18","author":"Saji","year":"2011","journal-title":"J Bronchol Intervent Pulmonol"},{"key":"2026032101152740900_bib36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1440-1843.2010.01871.x","article-title":"Comparison of 21-gauge and 22-gauge aspiration needle during endobronchial ultrasound-guided transbronchial needle aspiration","volume":"16","author":"Nakajima","year":"2011","journal-title":"Respirology"},{"key":"2026032101152740900_bib37","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1158\/1078-0432.CCR-10-0099","article-title":"Eml4-alk fusion gene assessment using metastatic lymph node samples obtained by endobronchial ultrasound-guided transbronchial needle aspiration","volume":"16","author":"Sakairi","year":"2010","journal-title":"Clin Cancer Res"},{"key":"2026032101152740900_bib38","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1378\/chest.10-3186","article-title":"Multi-gene mutation analysis of metastatic lymph nodes in non-small cell lung cancer diagnosed by EBUS-TBNA","volume":"140","author":"Nakajima","year":"2011","journal-title":"Chest"},{"key":"2026032101152740900_bib39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/JTO.0b013e31820517a3","article-title":"Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and kras molecular testing","volume":"6","author":"Rekhtman","year":"2011","journal-title":"J Thorac Oncol"},{"key":"2026032101152740900_bib40","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1097\/JTO.0b013e3181f77b58","article-title":"Treatment of lung cancer with an ALK inhibitor after eml4-alk fusion gene detection using endobronchial ultrasound-guided transbronchial needle aspiration","volume":"5","author":"Nakajima","year":"2010","journal-title":"J Thorac Oncol"},{"key":"2026032101152740900_bib41","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0046-8177(85)80106-4","article-title":"Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases","volume":"16","author":"Roggli","year":"1985","journal-title":"Hum Pathol"},{"key":"2026032101152740900_bib42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0031-1272866","article-title":"Pathological diagnosis and classification of lung cancer in small biopsies and cytology: strategic management of tissue for molecular testing","volume":"32","author":"Travis","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"2026032101152740900_bib43","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/cncr.22767","article-title":"Reliability of cytologic diagnosis of early lung cancer","volume":"111","author":"Vazquez","year":"2007","journal-title":"Cancer"},{"key":"2026032101152740900_bib44","first-page":"92","article-title":"Cytological cell blocks: predictors of squamous cell carcinoma and adenocarcinoma subtypes","volume":"39","author":"Loukeris","year":"2010","journal-title":"Diagn Cytopathol"},{"key":"2026032101152740900_bib45","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/JTO.0b013e318206a221","article-title":"International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma","volume":"6","author":"Travis","year":"2011","journal-title":"J Thorac Oncol"},{"key":"2026032101152740900_bib46","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1183\/09031936.00176410","article-title":"Accuracy of cell typing in non-small cell lung cancer by EBUS\/EUS - FNA cytology samples","volume":"38","author":"Wallace","year":"2011","journal-title":"Eur Respir J"},{"key":"2026032101152740900_bib47","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1378\/chest.06-1437","article-title":"Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging: a systematic review and metaanalysis","volume":"131","author":"Micames","year":"2007","journal-title":"Chest"},{"key":"2026032101152740900_bib48","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/cncr.9046","article-title":"Immediate on-site interpretation of fine-needle aspiration smears: a cost and compensation analysis","volume":"93","author":"Layfield","year":"2001","journal-title":"Cancer"},{"key":"2026032101152740900_bib49","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jcp.2006.038901","article-title":"Endobronchial ultrasound-guided fine-needle aspiration and liquid-based thin-layer cytology","volume":"60","author":"Wallace","year":"2007","journal-title":"J Clin Pathol"},{"key":"2026032101152740900_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/dc.10065","article-title":"Diagnostic value and cost-effectiveness of on-site evaluation of fine-needle aspiration specimens: review of 5,688 cases","volume":"27","author":"Nasuti","year":"2002","journal-title":"Diagn Cytopathol"},{"key":"2026032101152740900_bib51","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/JTO.0b013e318200f496","article-title":"How I do it: optimal methodology for multidirectional analysis of endobronchial ultrasound-guided transbronchial needle aspiration samples","volume":"6","author":"Nakajima","year":"2011","journal-title":"J Thorac Oncol"},{"key":"2026032101152740900_bib52","first-page":"889","article-title":"\u201cPick and smear\u201d tissue concentration technique for bloody aspirates","volume":"45","author":"Giri","year":"2001","journal-title":"Acta Cytol"},{"key":"2026032101152740900_bib53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/cncy.20151","article-title":"EGFR and kras mutations in lung carcinoma: molecular testing by using cytology specimens","volume":"119","author":"Billah","year":"2011","journal-title":"Cancer Cytopathol"},{"key":"2026032101152740900_bib54","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/jcp.2009.074328","article-title":"The role of endobronchial ultrasound guided transbronchial needle aspiration cytology in the investigation of mediastinal lymphadenopathy and masses. The North Tees experience","volume":"63","author":"Natu","year":"2010","journal-title":"J Clin Pathol"},{"key":"2026032101152740900_bib55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/00313028909059552","article-title":"Optimal formalin fixation and processing schedule of cell blocks from fine needle aspirates","volume":"21","author":"Kung","year":"1989","journal-title":"Pathology"},{"key":"2026032101152740900_bib56","article-title":"Endobronchial ultrasound-guided transbronchial needle aspiration for diagnosis and staging of thoracic malignancy: sensitivity and optimization of the cytologic specimen","author":"Bulman"},{"key":"2026032101152740900_bib57","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/JTO.0b013e3181d57f6e","article-title":"Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift","volume":"5","author":"Travis","year":"2010","journal-title":"J Thorac Oncol"},{"key":"2026032101152740900_bib58","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1634\/theoncologist.2010-0155","article-title":"Assessment of epidermal growth factor receptor and k-ras mutation status in cytological stained smears of non-small cell lung cancer patients: correlation with clinical outcomes","volume":"16","author":"Lozano","year":"2011","journal-title":"Oncologist"},{"key":"2026032101152740900_bib59","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1097\/JTO.0b013e3181f0bd93","article-title":"A brief retrospective report on the feasibility of epidermal growth factor receptor and kras mutation analysis in transesophageal ultrasound- and endobronchial ultrasound-guided fine needle cytological aspirates","volume":"5","author":"Schuurbiers","year":"2010","journal-title":"J Thorac Oncol"},{"key":"2026032101152740900_bib60","doi-asserted-by":"crossref","first-page":"75ra26","DOI":"10.1126\/scitranslmed.3002003","article-title":"Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors","volume":"3","author":"Sequist","year":"2011","journal-title":"Science Translational Medicine"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/185\/6\/606\/67292785\/ajrccm_185_6_606.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/185\/6\/606\/67292785\/ajrccm_185_6_606.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:15:39Z","timestamp":1774070139000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/185\/6\/606\/8508073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":60,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,3,15]]},"published-print":{"date-parts":[[2012,3,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201107-1199ci","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,3]]},"published":{"date-parts":[[2012,3]]}}}